These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32950345)

  • 21. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report.
    Weinberg D; Running K; Kalarickal PL; Patel GP
    Transplant Proc; 2021 May; 53(4):1300-1302. PubMed ID: 33246585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
    Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
    Wieruszewski PM; Nei SD; Maltais S; Schaff HV; Wittwer ED
    A A Pract; 2018 Aug; 11(4):96-99. PubMed ID: 29634537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.
    Ortoleva JP; Cobey FC
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1310-1314. PubMed ID: 30598380
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin II for Critically Ill Patients With Shock After Heart Transplant.
    Cutler NS; Rasmussen BM; Bredeck JF; Lata AL; Khanna AK
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2756-2762. PubMed ID: 32868151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Can We Define a Place in Therapy for Angiotensin II After Cardiac Surgery?
    Edwin SB
    J Cardiothorac Vasc Anesth; 2021 Jun; 35(6):1903. PubMed ID: 33129640
    [No Abstract]   [Full Text] [Related]  

  • 28. [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
    Durán Bruce M; Gomar Sancho C; Holguera JC; Muliterno Español E
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):246-53. PubMed ID: 24507583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Underutilized Fuel: Angiotensin II for Vasoplegia in the Heart Failure Patient Population.
    Alam A; Burkhoff D; Enter DH; Jermyn R
    J Cardiothorac Vasc Anesth; 2021 Dec; 35(12):3843. PubMed ID: 33975791
    [No Abstract]   [Full Text] [Related]  

  • 30. Commentary: Angiotensin II: Expanding the rescue options for vasoplegia.
    Augoustides JG
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1417-1418. PubMed ID: 33985809
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.
    Omar S; Zedan A; Nugent K
    Am J Med Sci; 2015 Jan; 349(1):80-8. PubMed ID: 25247756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
    Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoplegia treatments: the past, the present, and the future.
    Levy B; Fritz C; Tahon E; Jacquot A; Auchet T; Kimmoun A
    Crit Care; 2018 Feb; 22(1):52. PubMed ID: 29486781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Pilot, Double-Blind, Randomized, Controlled Trial of High-Dose Intravenous Vitamin C for Vasoplegia After Cardiac Surgery.
    Yanase F; Bitker L; Hessels L; Osawa E; Naorungroj T; Cutuli SL; Young PJ; Ritzema J; Hill G; Latimer-Bell C; Hunt A; Eastwood GM; Hilton A; Bellomo R
    J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):409-416. PubMed ID: 31526557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methylene blue therapy for vasoplegia after cardiac surgery].
    Skuza K; Chmielniak S; Dziuk W; Kucewicz E; Pawlak S; Knapik P
    Anestezjol Intens Ter; 2009; 41(3):159-62. PubMed ID: 19999604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoresponsiveness in patients with heart failure (VASOR): protocol for a prospective observational study.
    van Vessem ME; Beeres SLMA; de Wilde RBP; de Vries R; Berendsen RR; de Jonge E; Danser AHJ; Klautz RJM; Schalij MJ; Palmen M
    J Cardiothorac Surg; 2019 Nov; 14(1):200. PubMed ID: 31752946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylene blue is not a pure vasoconstrictor drug.
    Evora PR
    Ann Card Anaesth; 2016; 19(2):340-1. PubMed ID: 27052080
    [No Abstract]   [Full Text] [Related]  

  • 38. Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms.
    Charles FG; Murray LJ; Giordano C; Spiess BD
    Can J Anaesth; 2019 Dec; 66(12):1501-1513. PubMed ID: 31346957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. eComment. Potential therapeutic agents in vasoplegic syndrome after cardiac surgery.
    Yavuz S; Toktas F; Surer S; Eris C
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):530-1. PubMed ID: 23956362
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk factors for vasoplegia after cardiac surgery: a meta-analysis.
    Dayan V; Cal R; Giangrossi F
    Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):838-844. PubMed ID: 30649312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.